CIK 0001563665 · Non-accelerated filer<br>Smaller reporting company
Harvard Apparatus Regenerative Technology, Inc.
Sign in to watch- Ticker
- HRGN
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 455210462
- Phone
- (774) 233-7300
- Business address
- 84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA, 01746
- Former names
- Biostage, Inc.
- Open-market buys, last 90 days
- $394,459
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$394,459. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-15 | He Junli CEO | Purchase | +6,725 | $2.15 | $14K | 1,332,930 |
| 2026-09-11 | He Junli CEO | Conversion | +683,725 | $1.05 | $718K | 964,300 |
| 2026-09-11 | He Junli CEO | Purchase | +361,905 | $1.05 | $380K | 1,326,205 |
| 2026-09-11 | He Junli CEO | Conversion · Bridge Note (04/14/2026) | −310,000 | 0 | ||
| 2026-09-11 | He Junli CEO | Conversion · Bridge Note (05/13/2026) | −205,378 | 0 | ||
| 2026-09-11 | He Junli CEO | Conversion · Bridge Note (07/16/2026) | −202,533 | 0 | ||
| 2026-07-21 | He Junli CEO | Grant or award · Nonqualified Stock Option (right to buy), time-based tranche | +600,000 | 600,000 | ||
| 2026-07-21 | He Junli CEO | Grant or award · Nonqualified Stock Option (right to buy), performance-based | +600,000 | 600,000 | ||
| 2025-11-25 | He Junli CEO | Purchase | +3,000 | $1.70 | $5K | 280,575 |
| 2025-09-30 | He Junli CEO | Purchase | +300 | $1.98 | $594 | 277,575 |
| 2025-09-02 | He Junli CEO | Purchase | +11,225 | $1.85 | $21K | 277,275 |
| 2025-08-21 | He Junli CEO | Purchase | +4,050 | $1.72 | $7K | 266,050 |
| 2025-06-27 | Zhang Mao Director | Grant or award · Stock Option (right to buy) | +18,590 | 18,590 | ||
| 2025-06-27 | Zhang Mao Director | Grant or award · Stock Option (right to buy) | +15,227 | 15,227 | ||
| 2025-06-27 | Shmerling James E. Director | Grant or award · Stock Option (right to buy) | +18,590 | 18,590 | ||
| 2025-06-27 | Shmerling James E. Director | Grant or award · Stock Option (right to buy) | +15,227 | 15,227 | ||
| 2025-06-27 | Sanchez Herman Director | Grant or award · Stock Option (right to buy) | +18,590 | 18,590 | ||
| 2025-06-27 | Sanchez Herman Director | Grant or award · Stock Option (right to buy) | +15,227 | 15,227 | ||
| 2025-06-27 | Packard Ronald J Director | Grant or award · Stock Option (right to buy) | +18,590 | 18,590 | ||
| 2025-06-27 | Packard Ronald J Director | Grant or award · Stock Option (right to buy) | +15,227 | 15,227 |
Page 1 of 10 · 182 trades